Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 EUR | +1.01% | 0.00% | -19.79% |
04-25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-23 | Transcript : Heidelberg Pharma AG - Special Call |
Business Summary
Number of employees: 95
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugates
100.0
%
| 19 | 100.0 % | 10 | 100.0 % | -46.75% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
48.1
%
| 8 | 44.3 % | 5 | 48.1 % | -42.22% |
United States
47.4
%
| 9 | 48.5 % | 5 | 47.4 % | -47.98% |
Rest of the World
2.5
%
| 1 | 3.9 % | 0 | 2.5 % | -66.71% |
Switzerland
1.5
%
| 0 | 0.3 % | 0 | 1.5 % | +178.85% |
Germany
0.6
%
| 1 | 3.0 % | 0 | 0.6 % | -89.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Pahl
CEO | Chief Executive Officer | - | 31/12/11 |
Walter Miller
DFI | Director of Finance/CFO | - | 30/04/23 |
András Strassz
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
Jörg Kemkowski
COO | Chief Operating Officer | - | 31/12/22 |
Sylvia Wimmer
IRC | Investor Relations Contact | - | 30/11/99 |
George Badescu
PRN | Corporate Officer/Principal | - | 31/10/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 28/04/05 | |
Georg F. Baur
BRD | Director/Board Member | 74 | 13/12/00 |
Birgit Kudlek
BRD | Director/Board Member | 57 | 24/05/12 |
Christof Hettich
CHM | Chairman | 64 | 20/05/10 |
Mathias Hothum
BRD | Director/Board Member | 58 | 29/07/15 |
Dong Zhou Liu
BRD | Director/Board Member | - | 27/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,604,977 | 7,896,350 ( 16.94 %) | 0 | 16.94 % |
Company contact information
Heidelberg Pharma AG
Gregor-Mendel-Strasse 22
68526, Ladenburg
+49 6203 1009 0
http://heidelberg-pharma.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.79% | 148M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- HPHA Stock
- Company Heidelberg Pharma AG